Pet Pharm Biotech Co., Ltd. (TPEX:7762)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
84.30
+3.40 (4.20%)
At close: Sep 19, 2025

Pet Pharm Biotech Revenue

Pet Pharm Biotech had revenue of 42.13M TWD in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 159.02M. In the year 2024, Pet Pharm Biotech had annual revenue of 130.70M with 10.89% growth.

Revenue (ttm)
159.02M
Revenue Growth
+10.89%
P/S Ratio
27.27
Revenue / Employee
n/a
Employees
n/a
Market Cap
4.34B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024130.70M12.83M10.89%
Dec 31, 2023117.87M42.13M55.62%
Dec 31, 202275.74M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition